Triple-Negative Breast Cancer (TNBC) Completed Phase 1 Trials for Etarfolatide (DB11810)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01999738Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid TumorsTreatment